Tel Aviv [Israel], April 24 (ANI/ TPS): India's Sun Pharma and Israel's Moebius Medical published new data on MM-II, a non-opioid treatment for knee osteoarthritis. The studies, featured in the peer-reviewed Osteoarthritis and Cartilage journal, show that a single injection of MM-II can provide long-lasting pain relief and protect cartilage.
The drug, developed in Israel and supported by Sun Pharma, recently received Fast Track Designation from the US FDA. New findings will be presented at the OARSI 2025 World Congress. (ANI/ TPS)
You may also like
Paul Merson makes Arsenal Champions League prediction ahead of PSG showdown - 'Carried away'
'That's private' - Chelsea sent clear Liam Delap transfer message ahead of summer transfer window
Asaduddin Owaisi lauds CCS decisions in wake of Pahalgam terror attack
John Higgins makes Ally McCoist howl with joke about World Snooker Championship rival
Pahalgam terror attack shows Pakistan's calculated diplomacy-terror operation
